Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.

MLA

Carter, John-Paul, et al. “Cochrane Corner: PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease.” Heart (British Cardiac Society), vol. 108, no. 1, Jan. 2022, pp. 14–15. EBSCOhost, https://doi.org/10.1136/heartjnl-2021-319629.

APA

Carter, J.-P., Hingorani, A. D., Wilkins, J., & Schmidt, A. F. (2022). Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Heart (British Cardiac Society), 108(1), 14–15. https://doi.org/10.1136/heartjnl-2021-319629

Chicago

Carter, John-Paul, Aroon D Hingorani, John Wilkins, and Amand Floriaan Schmidt. 2022. “Cochrane Corner: PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease.” Heart (British Cardiac Society) 108 (1): 14–15. doi:10.1136/heartjnl-2021-319629.